1. Home
  2. INTS vs BTOC Comparison

INTS vs BTOC Comparison

Compare INTS & BTOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$4.10

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.29

Market Cap

13.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTS
BTOC
Founded
2012
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
13.5M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
INTS
BTOC
Price
$4.10
$0.29
Analyst Decision
Buy
Hold
Analyst Count
3
1
Target Price
$38.00
$2.00
AVG Volume (30 Days)
30.3K
34.8K
Earning Date
05-07-2026
05-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$190,408,258.00
Revenue This Year
N/A
$34.89
Revenue Next Year
N/A
$14.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.03
52 Week Low
$0.22
$0.23
52 Week High
$8.06
$1.45

Technical Indicators

Market Signals
Indicator
INTS
BTOC
Relative Strength Index (RSI) 41.78 56.41
Support Level $3.95 $0.25
Resistance Level $5.09 $0.32
Average True Range (ATR) 0.32 0.02
MACD -0.05 0.00
Stochastic Oscillator 8.94 74.92

Price Performance

Historical Comparison
INTS
BTOC

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

Share on Social Networks: